Abstract
This work extends in vitro screening of antimicrobial activity of the sesquiterpene hydroquinone avarol, a main secondary metabolite of the Mediterranean sponge species Dysidea avara. The antimicrobial activity was in part evaluated by microdilution method against selected bacterial and fungal strains. Additionally, the screening included evaluation of anti-quorum sensing (anti-QS) effects. At a different extent avarol was proven to be active against all the microorganisms tested (MIC 0.002-0.008 mg/mL and MBC 0.004-0.016 mg/mL; MIC 0.004-0.015 mg/mL and MFC 0.008-0.030 mg/mL; respectively). This marine natural product also showed moderate anti-QS effects, reducing Pseudomonas aeruginosa PAO1 biofilm formation (75%), its twitching and protrusions motilities as well as pyocianin production (39%). According to the best of our knowledge, this is the first report both on avarol anti Gram-negative bacterial activity and anti-QS effects.
Keywords: Anti-quorum sensing effects, Dysidea avara, Gram-negative bacteria, natural product, Pseudomonas aeruginosa PAO1.
Current Pharmaceutical Biotechnology
Title:Further in vitro Evaluation of Antimicrobial Activity of the Marine Sesquiterpene Hydroquinone Avarol
Volume: 15 Issue: 6
Author(s): Boris Pejin, Carmine Iodice, Giuseppina Tommonaro, Bojana Stanimirovic, Ana Ciric, Jasmina Glamoclija, Milos Nikolic, Salvatore De Rosa and Marina Sokovic
Affiliation:
Keywords: Anti-quorum sensing effects, Dysidea avara, Gram-negative bacteria, natural product, Pseudomonas aeruginosa PAO1.
Abstract: This work extends in vitro screening of antimicrobial activity of the sesquiterpene hydroquinone avarol, a main secondary metabolite of the Mediterranean sponge species Dysidea avara. The antimicrobial activity was in part evaluated by microdilution method against selected bacterial and fungal strains. Additionally, the screening included evaluation of anti-quorum sensing (anti-QS) effects. At a different extent avarol was proven to be active against all the microorganisms tested (MIC 0.002-0.008 mg/mL and MBC 0.004-0.016 mg/mL; MIC 0.004-0.015 mg/mL and MFC 0.008-0.030 mg/mL; respectively). This marine natural product also showed moderate anti-QS effects, reducing Pseudomonas aeruginosa PAO1 biofilm formation (75%), its twitching and protrusions motilities as well as pyocianin production (39%). According to the best of our knowledge, this is the first report both on avarol anti Gram-negative bacterial activity and anti-QS effects.
Export Options
About this article
Cite this article as:
Pejin Boris, Iodice Carmine, Tommonaro Giuseppina, Stanimirovic Bojana, Ciric Ana, Glamoclija Jasmina, Nikolic Milos, Rosa De Salvatore and Sokovic Marina, Further in vitro Evaluation of Antimicrobial Activity of the Marine Sesquiterpene Hydroquinone Avarol, Current Pharmaceutical Biotechnology 2014; 15 (6) . https://dx.doi.org/10.2174/138920101506140910152253
DOI https://dx.doi.org/10.2174/138920101506140910152253 |
Print ISSN 1389-2010 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4316 |
Call for Papers in Thematic Issues
Artificial Intelligence in Bioinformatics
Bioinformatics is an interdisciplinary field that analyzes and explores biological data. This field combines biology and information system. Artificial Intelligence (AI) has attracted great attention as it tries to replicate human intelligence. It has become common technology for analyzing and solving complex data and problems and encompasses sub-fields of machine ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Synthesis and Biological Evaluation of 2, 3-Diaryl substituted-1, 3-thiazolidin-4-ones as Anti-HIV Agents
Medicinal Chemistry Review on Diagnostic Methods for SARS-CoV-2
Coronaviruses Recent Advances and Challenges of the Drugs Acting on Monoamine Transporters
Current Medicinal Chemistry Beneficial Effects of N-acetylcysteine and N-mercaptopropionylglycine on Ischemia Reperfusion Injury in the Heart
Current Medicinal Chemistry Synthetic Approaches to Aryl Halomethyl Sulfones
Current Organic Chemistry An Overview of Innovations in Analysis and Beneficial Health Effects of Wine Polyphenols
Mini-Reviews in Medicinal Chemistry Peptide-Oligonucleotide Hybrids in Antisense Therapy
Mini-Reviews in Medicinal Chemistry Synthesis of Some Novel 4-(Arylideneamino)-N'-((2-chloro-8-methylquinolin- 3-yl)methylene)-3-phenyl-2-thioxo-2,3-dihydrothiazole-5-carbohydrazides as Potential Antimicrobial Agents
Letters in Drug Design & Discovery An Atypical Case of Fulminant Interstitial Pneumonitis Induced by Carbamazepine
Current Drug Safety An Investigation Using Specific Absorption Rate Analysis to Diagnose Early- stage Breast Tumor using UWB Antenna
Current Medical Imaging γ-Secretase as a Therapeutic Target for the Treatment of Alzheimers Disease
Current Pharmaceutical Design A Review on Hemisynthesis, Biosynthesis, Biological Activities, Mode of Action, and Structure-Activity Relationship of Podophyllotoxins: 2003- 2007
Current Medicinal Chemistry COVID-19 Pandemic: How can Computer-assisted Methods help to Rein in this Global Menace?
Current Computer-Aided Drug Design Promises of Molecular Pharmaceutics in the Development of Novel Drug Delivery Formulations
Current Drug Delivery Computational Studies on Translocator Protein (TSPO) and its Ligands
Current Topics in Medicinal Chemistry COVID-19 and Kidney Disease: A Clinical Perspective
Current Vascular Pharmacology Transposable Elements and their Use for Target Site Specific Gene Delivery
Current Pharmacogenomics Docking Screens: Right for the Right Reasons?
Current Topics in Medicinal Chemistry Virtual Screening Studies for Discovery of Novel Inhibitors of Inflammatory Process Targets
Current Pharmaceutical Design ICE Regimen for Relapsed/Refractory Bone and Soft Tissue Sarcomas in Children
Reviews on Recent Clinical Trials